Perinatal lethal Gaucher disease: A case report and review of literature

Brain Dev. 2023 Feb;45(2):134-139. doi: 10.1016/j.braindev.2022.09.006. Epub 2022 Oct 8.

Abstract

Perinatal lethal Gaucher disease is a very rare variant of type 2 Gaucher disease that occurs in the neonatal period and leads to death in early infancy. The disease is characterized by hydrops fetalis or a collodion baby phenotype accompanied with progressive neurological manifestations, hepatosplenomegaly, thrombocytopenia, anemia, and failure to thrive. We report a case of perinatal lethal Gaucher disease treated with enzyme replacement therapy (ERT) who survived for 9 months and present a literature review of perinatal lethal Gaucher disease cases. The prognosis of perinatal lethal Gaucher disease is poor, and ERT is only effective in visceral manifestation. Therefore, palliative care should be recognized as a treatment option, and ERT employment needs to be discussed in this context.

Keywords: Enzyme replacement therapy; GBA gene; Gaucher disease; Glucocerebrosidase; Imiglucerase.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Enzyme Replacement Therapy
  • Female
  • Gaucher Disease* / complications
  • Glucosylceramidase / genetics
  • Humans
  • Hydrops Fetalis
  • Pregnancy

Substances

  • Glucosylceramidase

Supplementary concepts

  • Gaucher Disease, Perinatal Lethal